Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 7967984)

1.

Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.

Fine PE, Sterne JA, Pönnighaus JM, Rees RJ.

Lancet. 1994 Nov 5;344(8932):1245-9.

PMID:
7967984
2.
3.

Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.

Rivoire BL, Groathouse NA, TerLouw S, Neupane KD, Ranjit C, Sapkota BR, Khadge S, Kunwar CB, Macdonald M, Hawksworth R, Thapa MB, Hagge DA, Tibbals M, Smith C, Dube T, She D, Wolff M, Zhou E, Makhene M, Mason R, Sizemore C, Brennan PJ.

PLoS Negl Trop Dis. 2014 May 29;8(5):e2811. doi: 10.1371/journal.pntd.0002811. eCollection 2014. Erratum in: PLoS Negl Trop Dis. 2014 Jul;8(7):e3065. Kunwar, Chatra B [corrected to Kunwar, Chhatra B].

4.
5.

Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.

Düppre NC, Camacho LA, Sales AM, Illarramendi X, Nery JA, Sampaio EP, Sarno EN, Bührer-Sékula S.

PLoS Negl Trop Dis. 2012;6(6):e1711. doi: 10.1371/journal.pntd.0001711. Epub 2012 Jun 19.

6.

A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.

Wang C, Chen Z, Fu R, Zhang Y, Chen L, Huang L, Li J, Shi C, Fan X.

Med Microbiol Immunol. 2011 Aug;200(3):165-75. doi: 10.1007/s00430-011-0188-z. Epub 2011 Feb 22.

PMID:
21340709
7.

Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.

Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A, Whittle H, McShane H, Rowland-Jones SL, Flanagan KL.

J Immunol. 2010 Aug 15;185(4):2620-8. doi: 10.4049/jimmunol.1000552. Epub 2010 Jul 19.

8.

Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.

Strapagiel D, Kasztalska K, Druszczyńska M, Kowalewicz-Kulbat M, Vrba A, Matusiak A, Chmiela M, Rudnicka W.

Folia Histochem Cytobiol. 2008;46(3):353-9. doi: 10.2478/v10042-008-0044-1.

9.

Tuberculosis vaccine development: goals, immunological design, and evaluation.

Hoft DF.

Lancet. 2008 Jul 12;372(9633):164-75. doi: 10.1016/S0140-6736(08)61036-3. Review.

PMID:
18620952
10.

Vaccination with the murine type of tubercle bacillus (vole bacillus).

WELLS AQ.

Lancet. 1949 Jul 9;2(6567):53-5. No abstract available.

PMID:
18133888
11.

Long lasting BCG protection against leprosy.

Rodrigues LC, Kerr-Pontes LR, Frietas MV, Barreto ML.

Vaccine. 2007 Sep 28;25(39-40):6842-4. Epub 2007 Aug 6.

PMID:
17728023
12.

Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.

Lin MY, Geluk A, Smith SG, Stewart AL, Friggen AH, Franken KL, Verduyn MJ, van Meijgaarden KE, Voskuil MI, Dockrell HM, Huygen K, Ottenhoff TH, Klein MR.

Infect Immun. 2007 Jul;75(7):3523-30. Epub 2007 May 14.

13.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
14.

Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.

Huang D, Qiu L, Wang R, Lai X, Du G, Seghal P, Shen Y, Shao L, Halliday L, Fortman J, Shen L, Letvin NL, Chen ZW.

J Infect Dis. 2007 Jan 1;195(1):55-69. Epub 2006 Nov 22.

15.

The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.

Weir RE, Black GF, Nazareth B, Floyd S, Stenson S, Stanley C, Branson K, Sichali L, Chaguluka SD, Donovan L, Crampin AC, Fine PE, Dockrell HM.

Clin Exp Immunol. 2006 Dec;146(3):390-9.

16.

Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.

Horwitz MA, Harth G, Dillon BJ, Maslesa-Galić S.

Vaccine. 2006 Jan 23;24(4):443-51. Epub 2005 Aug 11.

PMID:
16125825
17.

A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.

Castañon-Arreola M, López-Vidal Y, Espitia-Pinzón C, Hernández-Pando R.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):115-26. Epub 2005 Jan 22.

PMID:
15687035
18.

Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.

Gormus BJ, Meyers WM.

Expert Rev Vaccines. 2003 Dec;2(6):791-804. Review.

PMID:
14711362
19.

Immunisation for thrombosis and arteriosclerosis.

ROGERS JH.

Lancet. 1963 Jan 19;1(7273):175. No abstract available.

PMID:
13982393
20.

Skin transplantation immunity in relation to hypersensitivity.

BRENT L, BROWN J, MEDAWAR PB.

Lancet. 1958 Sep 13;2(7046):561-4. No abstract available.

PMID:
13576872
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk